ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 68 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $410,000 | +1.2% | 50,000 | -50.0% | 0.11% | -53.3% |
| Q4 2016 | $405,000 | -80.9% | 100,000 | -66.7% | 0.24% | -35.8% |
| Q3 2016 | $2,116,000 | +29.8% | 300,000 | +50.0% | 0.38% | -43.1% |
| Q2 2016 | $1,630,000 | -19.8% | 200,000 | -20.0% | 0.66% | -11.0% |
| Q1 2016 | $2,033,000 | -52.3% | 250,000 | -29.2% | 0.74% | -46.8% |
| Q4 2015 | $4,259,000 | +374.3% | 353,161 | +370.9% | 1.40% | +296.9% |
| Q3 2015 | $898,000 | – | 75,000 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 15,832,611 | $68,080,000 | 3.54% |
| Matrix Capital Management Company, LP | 28,000,000 | $120,400,000 | 3.21% |
| Virtus ETF Advisers LLC | 50,655 | $218,000 | 0.46% |
| TFG Asset Management GP Ltd | 500,000 | $2,150,000 | 0.27% |
| Rock Springs Capital Management LP | 800,000 | $3,440,000 | 0.13% |
| Orbimed Advisors | 1,350,655 | $5,808,000 | 0.09% |
| Vident Investment Advisory, LLC | 289,340 | $1,244,000 | 0.07% |
| WS MANAGEMENT LLLP | 185,537 | $798,000 | 0.05% |
| Rathbones Group PLC | 285,722 | $1,229,000 | 0.04% |
| Tekla Capital Management LLC | 228,496 | $983,000 | 0.04% |